Peter Amaya
Ohio State University
9 Papers
20 Citations
Peter Amaya is an academic researcher from Ohio State University. The author has contributed to research in topics: Circulating tumor cell & Cancer. The author has an hindex of 5, co-authored 9 publications.
Chat about Author
Papers
Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells.
João Paulo Oliveira-Costa,Alex Fiorini de Carvalho,Giórgia Gobbi da Silveira,Peter Amaya,Yongqi Wu,Kyoung-Joo Jenny Park,Mabel Gigliola,Maryam B. Lustberg,Marcilei E. Buim,Elisa Napolitano Ferreira,Luiz Paulo Kowalski,Jeffrey J. Chalmers,Fernando Augusto Soares,Dirce Maria Carraro,Alfredo Ribeiro-Silva +14 more
TL;DR: An important role for PD-L1 is demonstrated in primary tumors according to tumor size, and in disease specific survival, as well as in CTCs from patients with locally advanced OSCC.
Femtogram Resolution of Iron Content on a Per Cell Basis: Ex Vivo Storage of Human Red Blood Cells Leads to Loss of Hemoglobin
Jeffrey J. Chalmers,Xiaoxia Jin,Xiaoxia Jin,Andre F. Palmer,Mark H. Yazer,Lee R. Moore,Peter Amaya,Kyoung-Joo Jenny Park,X. Pan,Maciej Zborowski +9 more
TL;DR: Using a previously developed and reported instrument, cell tracking velocimetry (CTV), this Article is able to detect difference in Hb concentration in two RBC populations to a resolution of 1 × 107 Hb molecules per cell, the result of routine RBC storage.
25
Multiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA In Situ Hybridization and Immunocytochemical Analysis.
Yongqi Wu,Kyoung-Joo Jenny Park,Clayton Deighan,Peter Amaya,Brandon Miller,Quintin Pan,Maciej Zborowski,Maryam B. Lustberg,Jeffery J. Chalmers +8 more
TL;DR: Building on previous CTC research on CD45-based negative magnetic separation and four-color fluorescent immunocytochemical (ICC) staining, RNA in situ hybridization (ISH) was applied to fluorescently target mRNA sequences corresponding to tumor-related genes at the single CTC level and an integrated method of RNA ISH and fluorescent ICC staining was developed to visualize CTCs on both mRNA and protein levels.
Strain energy based failure criterion: Comparison of numerical predictions and experimental observations for symmetric composite laminates subjected to triaxial loading
Bradley M Doudican,Behrad Zand,Peter Amaya,Tarunjit S. Butalia,William E. Wolfe,G. A. Schoeppner +5 more
TL;DR: An analytical model to predict the constitutive response, failure initiation and post-initial failure behavior of fibrous composites under triaxial loading has been developed based on a strain energy model as mentioned in this paper.
15
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study
Robert Wesolowski,Daniel G. Stover,Maryam B. Lustberg,Abigail B. Shoben,Meng Zhao,Ewa Mrozek,Rachel M. Layman,Erin Macrae,Wenrui Duan,Jun Zhang,Nathan Hall,Chadwick Wright,Susan Gillespie,Michael Berger,Jeffrey J. Chalmers,Alahdra Carey,Priya Balasubramanian,Brandon Miller,Peter Amaya,Eleni Andreopoulou,Joseph A. Sparano,Charles L. Shapiro,Miguel A. Villalona-Calero,Susan Geyer,Alice P. Chen,Michael R. Grever,Michael V. Knopp,Bhuvaneswari Ramaswamy +27 more
TL;DR: A safety profile of veliparib and carboplatin in advanced breast cancer is established while also providing additional data on the potential for FLT‐PET imaging modality in monitoring therapy response.